TLISライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 00:35):

Stats
本日の出来高	7 065.00
平均出来高	9 104.00
時価総額	16.38M
EPS	$0 ( 2024-03-27 )
次の収益日	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.260
ATR14	$0.145 (1.61%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-01	Lukowiak Andrew A	Buy	30 575	Stock option (right to buy)
2023-08-01	Lukowiak Andrew A	Buy	0
2023-07-17	Markovich Rebecca	Buy	13 071	Stock option (right to buy)
2023-06-09	Baker Bros. Advisors Lp	Buy	23 685	Non- Qualified Stock Option (right to buy)
2023-06-09	Scott Randal W.	Buy	95 000	Stock option (right to buy)

INSIDER POWER
80.39
Last 91 transactions
Buy: 54 998 856 \| Sell: 42 065 023

Talis Biomedical 相関

10 最も正の相関
PAIC	0.926
SVAC	0.922
SVOK	0.891
MTSL	0.889
NSTS	0.859
TLGT	0.855
MOGO	0.851
GOODM	0.85
SKYX	0.844
KZIA	0.84

10 最も負の相関
AMRB	-0.929
NETE	-0.923
RAVN	-0.901
MMAC	-0.878
SRAC	-0.868
LWAC	-0.836
LMRKN	-0.807

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Talis Biomedical 財務諸表

Annual	2023
収益:	$412 000
総利益:	$-4.70M (-1 141.50 %)
EPS:	$-34.12

FY	2023
収益:	$412 000
総利益:	$-4.70M (-1 141.50 %)
EPS:	$-34.12

FY	2022
収益:	$3.65M
総利益:	$-4.74M (-129.76 %)
EPS:	$-62.45

FY	2021
収益:	$0.00
総利益:	$0.00 (0.00 %)
EPS:	$-8.48

Financial Reports:

No articles found.

Talis Biomedical

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California.